Allied Market Research
Loading...
0
Upcoming Allied Market Research
2021
Human Papillomavirus Vaccine Market

Human Papillomavirus Vaccine Market Type (Bivalent, Polyvalent), By Disease Indication (HPV Related Cancer, Genital Warts) Industry Vertical (Healthcare and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030.

A14328
Pages: NA
Jan 2022 | 24 Views
   
Author(s) : NA
Tables: NA
Charts: NA
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Human Papillomavirus Vaccine Market

Request Now !

Human Papillomavirus Vaccine has been widely known as a sweeping vaccine innovation for the universal advantage of all girls and women. Every year, lakhs of women develop cervical cancer, and thousands die from the disease. The majority of the deaths occur in developing countries. Currently, cervical cancer is one of the most common cancer in countries of South East Asia, while China recorded the uppermost peak in the incidence rate of cervical cancer globally. Globally, three HPV vaccines are developed and approved in more than 100 countries since 2008.

The demand for reducing HPV infections will fuel the market and create lucrative demand for HPV vaccines. As per the HPV Information Center, annual cases for cervical cancer were at the uppermost peak in the emerging countries in the year 2018.

Market scope and Structure Analysis

Report Metric 

Details

  Market Size Available for Years

  2021–2030

  Base Year Considered

 2020

  Forecast Period

  2021–2030

  Forecast Units

  Value (USD)

  Segments Covered

  Type, Application, Industry Vertical, and Region

  Geographies Covered

North America (U.S. and Canada), Europe (Germany, UK, France, and the Rest of Europe), Asia-Pacific (China, Japan, India, and the Rest of Asia-Pacific), Latin America (Brazil, Mexico, and the Rest of LATAM) and The Middle East and Africa

  Companies Covered

Merck & Co., Inc., GlaxoSmithKline plc., Sanofi, Johnson & Johnson, AstraZeneca, Serum Institute of India Pvt. Ltd., and Bharat Biotech.

 

COVID-19 Scenario Analysis
The outbreak of COVID-19 is likely to have a moderate impact on the market in the forecast period. R&D activities to identify the threat of SARS-CoV-2 virus on the patients suffering are likely to slow the market growth.
COVID-19 has brought about a significant burden on the healthcare industry globally, with disruption in the treatment of non-communicable diseases. Challenges exist in providing effective care.
Realizing the disturbing healthcare trends, governments are making efforts to provide excellent quality healthcare to patients globally. Nationwide lockdowns, canceled or postponed elective surgeries, denied wound care services, rise in skin injuries as part of COVID-19, the market is expected to show a decline during the forecast timeline. However, on the flip side, the latter half of the forecast is predicted to show a drastic rise.

Top impacting Factors: Market Scenario Analysis, Trends, Drivers and Impact Analysis
One of the most significant and crucial factors to drive the market is the protection and efficacy provided by HPV vaccines to decrease the adverse effects associated with infectious disease. As manufacturer developed novel vaccines for immunization, over the last decades, a change in beliefs and vaccination policies have been witnessed globally. This has gradually given rise to uptake and acceptability for HPV vaccines. Both polyvalent and bivalent vaccines have proved their safety and efficacy by the clinical trial process in protecting against cancer and HPV infections.
In addition, the rise in incidences of cervical cancer in countries is predicted to surge the sales of Human Papillomavirus Vaccine, and thus boost the growth of the market in the years to come. For example, Merk’s Gardasil with this, the increasing penetration of doses of vaccine in both the low and middle-income countries through immunization programs by the inter-governmental institutions like Pan American Health Organization (PAHO), World Health Organization (WHO), GAVI will positively pave the way to the HPV Vaccine sales globally.

Other factors that are witnessed to rise in the manufacturing capability of HPV vaccines to regulate the supply-demand of these vaccines globally. The ongoing supply of the vaccine is not sufficient to meet the demand, but this scenario is likely to be for the short term because of the rise in the number of countries to who are planning to develop HPV vaccines. For example, the Ministry of Ethiopia in December 2018, introduced the HPV vaccine by school approach for females under the age of 14 years to immunize the girl child against cervical cancer.

North America is likely to generate the most lucrative market in the years to come. Higher safe values of Gardasil/Gardasil 9 and adoption of the Human Papillomavirus Virus in the region are expected to drive the market. The presence of key players, and marketing channels are ensuring higher sales in the market. Asia-Pacific is predicted to witness rapid growth due to the prevalence of diseases and the growing population with an increase in disposable income. In addition, government initiatives and programs are expected to fuel the growth of the market for Human Papillomavirus Vaccine Market in the forecast timeline.

Key Segments Covered

Segments

Sub-segments

  Type

  • Bivalent
  • Polyvalent

 By Disease Indication

  • HPV Related Cancer
  • Genital Warts

  Industry Vertical

  • Healthcare
  • Others

 

 

 

 

 

 

 

 

 

Key Benefits of the Report

  • This study presents the analytical depiction of the global Human Papillomavirus Vaccine Market along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with a detailed analysis of the global Human Papillomavirus Vaccine Market share.
  • The current market is quantitatively analyzed from 2021 to 2030 to highlight the global Human Papillomavirus Vaccine Market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed global Human Papillomavirus Vaccine Market analysis based on competitive intensity and how the competition will take shape in coming years. 

Questions Answered in the Report

  • What are the leading market players active in the Human Papillomavirus Vaccine Market?
  • What current trends will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities in the market?
  • What are the projections for the future that would help in taking further strategic steps?

Report Tag: Tetravalent, Bivalent, Cervical Cancer, Vulvar & Vaginal Cancer, HPV Vaccine, Cancer Vaccine

 
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
PURCHASE OPTIONS

Start reading ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
 
Allied Market Research Allied Market Research Allied Market Research

Access from any device, anywhere

Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

FREQUENTLY ASKED
QUESTIONS?

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

REQUEST TOC/SAMPLE

OR

Purchase Full Report of
Human Papillomavirus Vaccine Market

Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,456  $3,110
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $3,840  $3,456
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $5,769  $5,192
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,450  $5,805
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $9,995  $8,996
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers